Inhibition of P38 Mitogen-Activated Protein Kinase Unmasks a CD30-triggered Apoptotic Pathway in Anaplastic Large Cell Lymphoma Cells

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2014English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2012English

P38 Mitogen-Activated Protein Kinase in Beryllium-Induced Dendritic Cell Activation

Human Immunology
MedicineAllergyImmunology
2014English

Contrast Bath-Induced Neurite Outgrowth in PC12m3 Cells via the P38 Mitogen-Activated Protein Kinase Pathway

Heliyon
Multidisciplinary
2019English

Anti-Neuroinflammatory Activity of Kamebakaurin From Isodon Japonicus via Inhibition of C-Jun NH2-Terminal Kinase and P38 Mitogen-Activated Protein Kinase Pathway in Activated Microglial Cells

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2011English

FAM172A Protein Promotes the Proliferation of Human Papillary Thyroid Carcinoma Cells via the P38 Mitogen-Activated Protein Kinase Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

P38 Mitogen-Activated Protein Kinase Inhibition Ameliorates Angiotensin II-Induced Target Organ Damage

Hypertension
Internal Medicine
2007English

Inhibition of P38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy